Alerts will be sent to your verified email
Verify Email
BDH
|
BDH Inds
|
Gennex Lab
|
Aptus Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.8 % | 8.73 % | 36.58 % |
|
5yr average Equity Multiplier
|
1.46 | 1.48 | 5.05 |
|
5yr Average Asset Turnover Ratio
|
0.89 | 0.67 | 1.72 |
|
5yr Avg Net Profit Margin
|
11.59 % | 9.84 % | 6.16 % |
|
Price to Book
|
3.26 | 1.07 | 32.44 |
|
P/E
|
22.09 | 12.97 | 72.88 |
|
5yr Avg Cash Conversion Cycle
|
-27.79 Days | 55.46 Days | 88.73 Days |
|
Inventory Days
|
31.79 Days | 55.63 Days | 64.83 Days |
|
Days Receivable
|
116.74 Days | 37.35 Days | 65.8 Days |
|
Days Payable
|
156.43 Days | 68.33 Days | 77.01 Days |
|
5yr Average Interest Coverage Ratio
|
78.47 | 6.72 | 6.23 |
|
5yr Avg ROCE
|
19.81 % | 11.78 % | 28.46 % |
|
5yr Avg Operating Profit Margin
|
14.91 % | 11.73 % | 10.95 % |
|
5 yr average Debt to Equity
|
0.1 | 0.18 | 2.26 |
|
5yr CAGR Net Profit
|
7.83 % | 35.01 % | 74.79 % |
|
5yr Average Return on Assets
|
10.19 % | 5.92 % | 8.44 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.7 % | 23.62 % | 72.89 % |
|
Share Pledged by Promoters
|
0.0 | 17.43 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | 0.24 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
BDH Inds
|
Gennex Lab
|
Aptus Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|